Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: A prospective clinical study
Osteoporosis International Sep 07, 2021
Park JH, Cho S, Kim SJ, et al. - For the prevention and early diagnosis of osteonecrosis of the jaw (ONJ), individuals with abnormally low serum levels of tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) and high serum levels of Dickkopf-related protein 1 (DKK1) should be monitored closely before and after dentoalveolar surgery.
Researchers designed a prospective study including a total of 76 patients who met the inclusion criteria; 33 were assigned to the ONJ group, and 43 patients without ONJ signs or symptoms after dentoalveolar surgery were assigned to the control group.
The results showed that at both T0 and T1, the mean tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) levels were significantly lower in the ONJ group and the mean Dickkopf-related protein 1 (DKK1) levels were significantly higher than the corresponding values for the control group.
In linear mixed model analysis, results demonstrated significant group effects over time for serum TRACP 5b and DKK1 after adjusting for demographic, pharmacological, and diagnostic variables.
It was shown that the lower serum levels of TRACP 5b under a specified cut-off value (≤ 2.899 U/L) at T0 indicated a 20.40-fold elevated risk of ONJ development.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries